GlassScriptPhysician profile
Berry J Byrd
NPI 1336637651
$4,326.35
in general payments reported to CMS, 2019-2025
32 companies · $2,376 in 2025
The $2,376 reported for 2025 was more than what 86% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $127 · 2021: $276 · 2022: $403 · 2023: $524 · 2024: $620 · 2025: $2,376.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,346 · Travel and Lodging: $1,174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,345.70 |
| Travel and Lodging | $1,174.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $1,044.60 | 2025 | Biobrace 23mm, Quantum |
| Medical Device Business Services, INC. | $702.44 | 2025 | Motoband |
| Smith+Nephew, INC. | $348.52 | 2019-2025 | Renasys Touch, Pico 7, Collagenase Santyl |
| Kerecis Limited | $346.37 | 2021-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen |
| Abbvie INC. | $292.10 | 2024-2025 | |
| Integra Lifesciences Corporation | $291.08 | 2022-2025 | Integra, Tenoglide, Primatrix |
| Orthofix Medical, INC. | $154.59 | 2021 | |
| Stryker Corporation | $122.78 | 2025 | Augment Injectable, Ortholoc 3di Crosscheck, Valor |
| Sanara Medtech INC. | $120.74 | 2023 | Celleraterx |
| Horizon Therapeutics Plc | $118.27 | 2021-2023 | Krystexxa |
| Treace Medical Concepts, INC. | $108.07 | 2025 | |
| Truvic Medical, INC. | $100.00 | 2022 | |
| Solventum Corporation | $73.45 | 2024-2025 | V.A.C. Veraflo, V.A.C.Ulta, Prevena |
| Polynovo North America LLC | $50.29 | 2022-2024 | Novosorb Btm |
| Convatec INC. | $47.27 | 2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $41.12 | 2025 | Foot Osteotomy Wedge System |
| Paratek Pharmaceuticals, INC. | $40.02 | 2022-2023 | Nuzyra |
| Acumed LLC | $35.40 | 2024 | Acumed |
| Aroa Biosurgery Incorporated | $35.23 | 2024 | |
| Kci USA, INC. | $27.28 | 2021-2022 | |
| Mimedx Group, INC. | $23.66 | 2024 | |
| Urgo Medical North America, LLC | $22.77 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Nevro Corp. | $22.65 | 2024 | Senza |
| Amgen INC. | $21.93 | 2025 | Krystexxa |
| Janssen Pharmaceuticals, INC | $18.98 | 2022 | |
| Organogenesis INC. | $18.37 | 2022 | |
| Inari Medical, INC. | $18.09 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic, INC. | $17.87 | 2025 | Inceptiv |
| Pinnacle, INC | $17.66 | 2023 | |
| Tactile Systems Technology INC | $16.37 | 2023 | Flexitouch Plus, Entre Plus |
| Next Science LLC | $14.79 | 2024 | Blastx, Xperience, Surgx |
| Bioventus LLC | $13.59 | 2024 | Exogen Ultrasound Bone Healing System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Berry Byrd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.